Keiretsu Capital

Call Directions Website Contact the business

Keiretsu Capital Keiretsu Capital administers funds on behalf of its Limited Partners - the Co-Investment & Opportunities Fund creates a diversified portfolio of companies.

b.well Connected Health is expanding what connected care can look like.b.well has been recognized by Samsung Health fo...
10/12/2026

b.well Connected Health is expanding what connected care can look like.
b.well has been recognized by Samsung Health for its work in connected care, including its inclusion in the Medicare App Library and support for initiatives designed to make healthcare more seamless and accessible.
By bringing health data and digital health tools together in one connected experience, b.well is helping create a more connected healthcare journey for patients.
Read more: https://news.samsung.com/us/samsung-health-recognized-connected-care-innovation-medicare-app-library-inclusion-recognition-excellence-support-clipboard/

Archax joined EuroFinance’s International Treasury Management 2026 in Barcelona, bringing its digital finance solution...
10/05/2026

Archax joined EuroFinance’s International Treasury Management 2026 in Barcelona, bringing its digital finance solutions to the Innovation Hub and contributing to conversations around the future of treasury.

At its roundtable, “24/7 Treasury,” the team explored auto-rolling T-Bills, faster MMF access, stablecoins and the growing role of tokenised treasury assets in reshaping treasury management.

A strong showing for Archax at the intersection of digital assets, tokenisation and institutional finance.

Read more: https://lnkd.in/p/gUVH5MRJ

Another Tomorrow has opened a five-month residency at Galeries Lafayette Haussmann in Paris, in collaboration with Stu...
09/28/2026

Another Tomorrow has opened a five-month residency at Galeries Lafayette Haussmann in Paris, in collaboration with Studio Patricia Urquiola.
The first chapter of the collaboration brings sustainable retail design to life through a regenerated, recyclable installation made with reclaimed mineral waste and repurposed organic matter, alongside sustainably sourced wood and predominantly renewable bioresin mannequins.
A thoughtful intersection of fashion, architecture and circular design, with Another Tomorrow’s Fall collection at the center. Know more: https://www.linkedin.com/posts/anothertomorrow_we-are-honored-to-open-today-at-galeries-activity-7500900483310534656-UQrR?utm_source=share&utm_medium=member_desktop&rcm=ACoAADM8h50B5DVJw6SLKOR4NzV-YZSBWDeviZ4

UbiQD is expanding its footprint in Los Alamos as it scales its next phase of growth.The quantum dot technology compan...
09/21/2026

UbiQD is expanding its footprint in Los Alamos as it scales its next phase of growth.

The quantum dot technology company has acquired an additional building adjacent to its existing headquarters, creating room for new manufacturing equipment, R&D, and future operations.

For an emerging deep-tech company, expanding physical infrastructure is more than a facilities milestone. It’s a sign that the business is building the capacity to take its technology from innovation to scale.

Read more: https://www.prnewswire.com/news-releases/ubiqd-expands-los-alamos-headquarters-campus-with-economic-development-support-302808833.html

OpZira has announced a strategic collaboration with Compvide to accelerate the growth and advancement of the CIMED™ pl...
09/14/2026

OpZira has announced a strategic collaboration with Compvide to accelerate the growth and advancement of the CIMED™ platform.

The collaboration brings together OpZira’s operational expertise with Compvide’s work in complement-focused diagnostics and precision medicine, supporting key areas including clinical development, manufacturing, regulatory, quality, and commercialization.

Read the full announcement: https://www.businesswire.com/news/home/20260716914366/en/Compvide-Announces-Strategic-Collaboration-with-OpZira-to-Accelerate-Growth-and-Advance-the-CIMED-Platform

InMedix is taking FDA-cleared HRV measurement nationwide.With the launch of CloudHRV, physicians across the U.S. can a...
09/07/2026

InMedix is taking FDA-cleared HRV measurement nationwide.

With the launch of CloudHRV, physicians across the U.S. can access clinical-grade HRV measurement through a cloud-based platform, bringing greater visibility into autonomic nervous system health.

A meaningful step forward for more accessible, data-driven healthcare.
Read the full announcement: https://www.einpresswire.com/article/931781565/inmedix-launches-cloudhrv-nationwide-bringing-fda-cleared-hrv-measurement-to-physicians-across-the-u-s

NuvOx Therapeutics has received FDA Fast Track designation for NanO₂™ for the treatment of acute ischemic stroke.The d...
08/31/2026

NuvOx Therapeutics has received FDA Fast Track designation for NanO₂™ for the treatment of acute ischemic stroke.
The designation marks an important milestone as NuvOx advances NanO₂, its oxygen therapeutic designed to address tissue hypoxia, through clinical development.
With Fast Track, NuvOx gains opportunities for more frequent FDA interactions and expedited review pathways as it continues evaluating NanO₂ alongside standard stroke therapies.
Read more: https://www.nuvoxtherapeutics.com/post/nuvox-therapeutics-receives-fda-fast-track-designation-to-nano-for-the-treatment-of-acute-ischemic

EternaTear is expanding its global footprint with a new licensing agreement covering select Asian markets.This milesto...
08/24/2026

EternaTear is expanding its global footprint with a new licensing agreement covering select Asian markets.

This milestone represents an important step toward increasing access to EternaTear's innovative dry eye treatment while accelerating the company's international commercialization strategy.

Learn more: https://www.linkedin.com/posts/eternatear_eternatear-license-agreement-for-select-asian-activity-7485736096258039809-fwOC?utm_source=share&utm_medium=member_desktop&rcm=ACoAADM8h50B5DVJw6SLKOR4NzV-YZSBWDeviZ4

Sinaptica Therapeutics is challenging the conventional approach to Alzheimer's disease by focusing on brain network dy...
08/17/2026

Sinaptica Therapeutics is challenging the conventional approach to Alzheimer's disease by focusing on brain network dysfunction rather than plaques and tangles alone.

Their latest conversation explores how precision neuromodulation and TMS-EEG could reshape the way Alzheimer's is understood, measured, and treated, offering a fresh perspective on one of healthcare's biggest challenges.

Watch the full discussion and learn how systems biology could help define the future of Alzheimer's research: https://youtu.be/rgogYc3lp7k?si=1fwbxw1PyLDPAyrt

Cascadia Seaweed was featured by New Ag International for its work advancing sustainable agriculture. Its BC processin...
08/10/2026

Cascadia Seaweed was featured by New Ag International for its work advancing sustainable agriculture. Its BC processing facility is scaling kelp-based biostimulants that support more resilient farming. Read more: https://tinyurl.com/2va66db6

Address

2815 Eastlake Avenue East, Suite 300
Seattle, WA
98102

Telephone

+12062558870

Website

Alerts

Be the first to know and let us send you an email when Keiretsu Capital posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Keiretsu Capital:

Shortcuts

Share

Category